Skip to main content
S 373 112th Congress Senate

Fair Prescription Drug Competition Act

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.

Introduced: February 16, 2011 See on congress.gov
Health Drug safety, medical device, and laboratory regulationPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 16, 2011
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 16, 2011
Sponsor introductory remarks on measure. (CR S797)
Feb 16, 2011
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 16, 2011

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Fair Prescription Drug Competition Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer.

 Related & companion bills 1
  • HR 741 Related bill To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2
D
Schumer, Charles E.
New York · Feb 16, 2011
 D
Shaheen, Jeanne
New Hampshire · Feb 16, 2011
Cite this page click to expand
APA
U.S. Congress. (2026). S. 373: Fair Prescription Drug Competition Act. 112th Congress. Open America. https://openamerica.io/bill/112-S-373/
MLA
"S. 373: Fair Prescription Drug Competition Act." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-S-373/.
Bluebook (legal)
S. 373, 112th Cong. (2026), https://openamerica.io/bill/112-S-373/.
Markdown link
[S. 373: Fair Prescription Drug Competition Act](https://openamerica.io/bill/112-S-373/)
Report a problem